Literature DB >> 33462449

The limits of acceptable political influence over the FDA.

Holly Fernandez Lynch1, Steven Joffe2, Matthew S McCoy2.   

Abstract

Year:  2021        PMID： 33462449     DOI： 10.1038/s41591-020-01200-w

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  3 in total

1.  Aspiring to Reasonableness in Accelerated Approval: Anticipating and Avoiding the Next Aducanumab.

Authors:  Emily A Largent; Andrew Peterson; Jason Karlawish; Holly Fernandez Lynch
Journal:  Drugs Aging       Date:  2022-06-13       Impact factor: 4.271

2.  Safeguarding evidence-based decision making in the FDA for COVID-19 vaccines.

Authors:  Aris Angelis; Jonathan Darrow
Journal:  Vaccine       Date:  2021-03-22       Impact factor: 3.641

3.  Perceptions of Regulatory Decision-Making for New Drugs From the Viewpoints of the Manufacturers in South Korea.

Authors:  Kyung-Bok Son; Sylvia Park
Journal:  Front Med (Lausanne)       Date:  2022-03-30
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.